Kato T, Inubushi T, Takahashi S
Department of Psychiatry, Shiga University of Medical Science, Japan.
J Clin Psychopharmacol. 1994 Oct;14(5):330-5.
Lithium concentrations in the brain were measured in 14 manic patients with bipolar disorder (12 with bipolar disorder, manic, and 2 with bipolar disorder, not otherwise specified, by DSM-III-R) by the use of lithium-7 magnetic resonance spectroscopy ([7Li]MRS). The reduction of Petterson Mania Rating Scale 4 weeks after the initiation of lithium treatment was not significantly correlated with concentrations in serum (r = 0.33), but was correlated with concentrations in the brain (r = 0.64; p < 0.05). These results suggest that the treatment response to lithium in manic patients with bipolar disorder is more closely related to the lithium concentration in the brain as measured by [7Li]MRS than to the concentration in serum.
通过使用锂-7磁共振波谱法([7Li]MRS),对14名双相情感障碍躁狂患者(12名双相情感障碍,躁狂发作,2名根据《精神疾病诊断与统计手册》第三版修订版诊断为双相情感障碍,未另行说明)的大脑锂浓度进行了测量。锂治疗开始4周后,彼得森躁狂评定量表的降低与血清浓度无显著相关性(r = 0.33),但与大脑浓度相关(r = 0.64;p < 0.05)。这些结果表明,双相情感障碍躁狂患者对锂的治疗反应与通过[7Li]MRS测量的大脑锂浓度的关系比与血清浓度的关系更为密切。